Recent Updates — AFJK

Aimei Health Technology deposited $34,330.96 into its trust account and issued an unsecured promissory note for the same amount to Aimei Investment Ltd. This payment funds a one-month extension of the deadline to consummate an initial business combination with United Hydrogen from October 6, 2026 to November 6, 2026. The extension is the twenty-third permitted under the company's articles. The promissory note bears no interest and becomes due upon the completion of the business combination, with a conversion option into private units at $10.00 per unit prior to closing. Aimei Health Technology Co., Ltd operates in the health technology sector.

On July 7, 2026, Aimei Health Technology Co., Ltd. terminated its Business Combination Agreement with United Hydrogen Group Inc. and its affiliated entities (United Hydrogen Global Inc., United Hydrogen Victor Limited, United Hydrogen Worldwide Limited, and Aimei Investment Ltd.). The agreement, originally entered into on June 19, 2024, and amended on June 6, 2025, will not be consummated. The company operates in the healthcare technology industry.

Ms. Julianne Huh resigned from the Board of Directors as a director, effective June 24, 2026, for personal reasons. The Board approved the appointment of Mr. Daniel Veikko Polvi to serve as a director, effective June 29, 2026. Aimei Health Technology Co., Ltd. operates in the health technology industry and provides health technology solutions.

Aimei Health Technology Co., Ltd. has extended its deadline to consummate a business combination from June 6, 2026, to July 6, 2026. The company issued an unsecured, interest-free promissory note totaling $34,330.96 to Aimei Health Ltd and United Hydrogen Group Inc. to fund the extension payment. The note holders have the option to convert the principal into private units at a price of $10.00 per unit prior to the business combination.